Elisabetta Bonzano MD, PhD路 @to_be_elizabeth 路 X路路 2 days agoScore70
Body 路 original
馃搶 Rapid Oral Breast Cancer, Early stage
鉁≒atient-reported outcomes from DESTINY-Breast05: HRQoL with T-DXd versus T-DM1 in patients with high-risk HER2-positive eBC
#ESMO26 馃嚜馃嚫 @OncoAlert #OncoAlertAF
235 views 路 6 likes 路 5 reposts 路 0 replies
Conference abstracts
539ROmatched by Rapid oral: Breast cancer, early stage
Patient-reported outcomes (PROs) from DESTINY-Breast05: Health-related quality of life (HRQoL) with trastuzumab Deruxtecan (T-DXd) versus trastuzumab emtansine (T-DM1) in patients (Pts) with high-risk HER2-positive early breast cancer (eBC)
https://esmocongress.esmo.orgSource: Elisabetta Bonzano MD, PhD 路 x.com